Delivery Order SPE2DB22D2009-SPE2DB25FL8RH
Award Date
4/3/25
Potential Completion Date
4/4/25
Potential Value
$8.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,847.40, is for the supply of the medication RINVOQ ER 15 MG TABLET. The contract is a firm fixed-price delivery order with an ultimate completion date of April 9, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,693.60, is for the delivery of the medication RINVOQ ER 30 MG TABLET UU 30S. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,113.48, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,223.32, is for the delivery of RINVOQ ER 30 MG TABLET UU 30S. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $26,492.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a medication, and has a completion date of February 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,962.91 firm fixed-price delivery order is for RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,954.88, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of March 12, 2025 and is a Firm Fixed Price Delivery Order. The contract award was not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,444.10 delivery order is a firm fixed-price contract for the supply of the prescription medication RINVOQ ER 30 MG TABLET UU 30S. The contract has a completion date of May 6, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a $18,046.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of the pharmaceutical product RINVOQ ER 15 MG TABLET, with a completion date of September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing this product through an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,995.81, is a delivery order for the medication RINVOQ ER 15 MG TABLET UU 30S. The contract has a firm fixed price pricing type and a completion date of April 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...